The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration-Reference-Cited by-同舟云学术

The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration

Published:2018-05-24 Issue:4 Volume:20 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Kourentas Alexandros,Vertzoni Maria,Barmpatsalou Vicky,Augustijns Patrick,Beato Stefania,Butler James,Holm Rene,Ouwerkerk Neils,Rosenberg Joerg,Tajiri Tomokazu,Tannergren Christer,Symillides Mira,Reppas Christos

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/article/10.1208/s12248-018-0231-8/fulltext.html

Reference41 articles.

1. Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, et al. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. J Pharm Sci. 2014;103:3377–97.

2. Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci. 2006;95:116–25.

3. Tsume G, Amidon L, Takeuchi S. Dissolution effect of gastric and intestinal pH for BCS class II drug, pioglitazone: new in vitro dissolution system to predict in vivo dissolution. J Bioequiv Availab. 2013;5:224–7.

4. Kourentas A, Vertzoni M, Stavrinoudakis N, Symillidis A, Brouwers J, Augustijns P, et al. An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation. Eur J Pharm Sci. 2016;80:106–14.

5. Ruff A, Holm R, Kostewicz ES. Evaluating the predictability of the in vitro transfer model and in vivo rat studies as a surrogate to investigate the supersaturation and precipitation behaviour of different albendazole formulations for humans. Eur J Pharm Sci. 2017;105:108–18.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report;Molecular Pharmaceutics;2024-07-01

2. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference;European Journal of Pharmaceutical Sciences;2023-11

3. Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary;European Journal of Pharmaceutical Sciences;2023-09

4. Screening for Differences in Early Exposure in the Fasted State with in Vitro Methodologies can be Challenging: Experience with the BioGIT System;Journal of Pharmaceutical Sciences;2023-08

5. Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form;F1000Research;2023-06-27